IDH1 (R132H)

    Neuropathology/Endocrine
    ZR7 Rabbit Monoclonal

    IDH1 R132H antibody binds to IDH1-mutated protein but does not bind the wild-type IDH1 protein. IDH1 R132H point mutations are frequently seen in World Health Organization grade II and III gliomas and are believed to constitute an early step in tumorigenesis. IDH1 R132H can be used as a diagnostic marker to help differentiate infiltrating gliomas from gliosis and as a prognostic marker for gliomas and secondary glioblastoma multiforme. IDH1 R132H antibody shows strong cytoplasmic staining and weaker nuclear staining in tumor cells with the R132H-mutated peptide. Diffuse staining of the fibrillary tumor matrix is also seen.

    Specifications
    Species Reactivity:Humans; others not tested
    Known Applications:Immunohistochemistry (formalin-fixed, paraffin-embedded tissues)
    Supplied As:Buffer with protein carrier and preservative
    Storage:Store at 2ºC to 8ºC
    Control:Infiltrating glioma
    Visualization:Nuclear
    Isotype:IgG
    Immunogen:Recombinant fragment of human IDH1 (exact sequence is proprietary)
    Ordering Information
    Classification IVD
    Catalogue Number Z2010RL
    Classification IVD
    Catalogue Number Z2010RL
    Package Inserts
    IFU-IDH1 (R132H) ZR7
    Regulatory Notice
    Product classification varies based on regulations of individual countries. Please contact your local distributor for more information. Products labeled as ASR or RUO in the US might be available as IVD or RUO in respective countries.
    SDS
    SDS